1. Market Research
  2. > Biotechnology
  3. > Genomics Market Trends
  4. > Epigenomics AG – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Summary
Marketline's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage.

This report includes Epigenomics AG's contact information and business summary, tables, graphs, a list of partners and targets, a breakdown of financial and legal advisors, deal types, top deals by deal value, detailed deal reports, and descriptions and contact details of the partner, target, investor, and vendor firms, where disclosed.

The profile also includes detailed deal reports for all M&A, private equity, public offering, venture financing, partnership and divestment transactions undertaken by Epigenomics AG. These deal reports contain information about target company financials, sources of financing, method of payment, deal values, and advisors for various parties, where disclosed.



Key Findings
Marketlines' Epigenomics AG Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by Epigenomics AG since January 2007.



Synopsis
- Provides intelligence on Epigenomics AG's M&A, strategic partnerships and alliances, capital raising and private equity transactions.

- Detailed reports of various financial transactions undertaken by Epigenomics AG and its subsidiaries since 2007.

- Information about key financial and legal advisors for Epigenomics AG's financial deals transactions.

- Financial deals tables and charts covering deal value and volumes trend, deal types and geography-based deal activity.



Reasons To Buy
- Access comprehensive financial deals data along with charts and graph covering M&A, private equity, and partnerships and alliances.

- Form an independent opinion about Epigenomics AG’s growth strategies through the organic and inorganic activities undertaken since 2007.

- Track your competitors’ business structure and growth strategies.


Key Highlights
This report includes Epigenomics AG's contact information and business summary, tables, graphs, a list of partners and targets, a breakdown of financial and legal advisors, deal types, top deals by deal value, detailed deal reports, and descriptions and contact details of the partner, target, investor, and vendor firms, where disclosed.

The profile also includes detailed deal reports for all M&A, private equity, public offering, venture financing, partnership and divestment transactions undertaken by Epigenomics AG. These deal reports contain information about target company financials, sources of financing, method of payment, deal values, and advisors for various parties, where disclosed.

Table Of Contents

Epigenomics AG - Mergers and Acquisitions (MandA), Partnerships and Alliances and Investment Report
Table of Contents


COMPANY OVERVIEW AND KEY FACTS
PARTNERSHIP
--Partnership - Overview
--Partnership - Deal reports
--Capital Raising - Deal reports
--Private Equity and Ownership - Deal reports

APPENDIX
--About MarketLine Financial Deals Database
--Deal Definition and Methodology
--About MarketLine
--MarketLine Professional Services Knowledge Center


List of Tables


--Epigenomics AG activity by deal type - volume (2015-TTM2016)
--Epigenomics AG activity by deal type - volume (2012 -YTD2016)
--Epigenomics AG legal advisor ranking by value ($m)
--Epigenomics AG targets and partners (2012 -YTD2016)
--Epigenomics AG partnership volume and value trend (2012-YTD2016)
--Epigenomics AG partnership trend by key deal type (2012-YTD2016)


List of Figures


--Epigenomics AG activity by deal type - volume (trailing twelve months (TTM))
--Epigenomics AG activity by deal type - volume (2012-YTD2016)
--Epigenomics AG partnership volume and value trend (2012-YTD2016)
--Epigenomics AG partnership trend by key deal type (2012-YTD2016)

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
IntegraGen SA (ALINT) - Product Pipeline Analysis, 2016 Update

IntegraGen SA (ALINT) - Product Pipeline Analysis, 2016 Update

  • $ 750
  • Company report
  • July 2016
  • by Global Data

Summary IntegraGen SA (IntegraGen) is a biotechnology company that offers clinical genomic services to academic researchers and life sciences companies. The company provides advanced bioinformatics and ...

Firalis SAS - Medical Equipment - Deals and Alliances Profile

Firalis SAS - Medical Equipment - Deals and Alliances Profile

  • $ 250
  • Company report
  • August 2016
  • by Global Data

Summary Firalis SAS (Firalis) is a biotechnology company that discovers and develops biomarkers and biomarker-based diagnostic kits. The company’s biomarker products include Elisa kits, recombinant proteins ...

Empire Genomics, LLC - Medical Equipment - Deals and Alliances Profile

Empire Genomics, LLC - Medical Equipment - Deals and Alliances Profile

  • $ 250
  • Company report
  • August 2016
  • by Global Data

Summary Empire Genomics, LLC (Genomics) is a medical device company that offers molecular diagnostic solutions. The company offers ID labs products, fish probes, BAC clones, genotyping and circulating ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.